| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA topoisomerase type II (double strand cut, ATP-hydrolyzing) activity | 5.49e-05 | 4 | 61 | 2 | GO:0003918 | |
| GeneOntologyMolecularFunction | nucleosome binding | 2.30e-04 | 98 | 61 | 4 | GO:0031491 | |
| GeneOntologyMolecularFunction | structural constituent of chromatin | 2.48e-04 | 100 | 61 | 4 | GO:0030527 | |
| GeneOntologyMolecularFunction | chromatin loop anchoring activity | 2.54e-04 | 8 | 61 | 2 | GO:0140587 | |
| GeneOntologyMolecularFunction | DNA topoisomerase activity | 2.54e-04 | 8 | 61 | 2 | GO:0003916 | |
| GeneOntologyMolecularFunction | DNA-DNA tethering activity | 3.26e-04 | 9 | 61 | 2 | GO:0106260 | |
| GeneOntologyMolecularFunction | chromatin binding | 3.84e-04 | 739 | 61 | 9 | GO:0003682 | |
| GeneOntologyMolecularFunction | single-stranded DNA binding | 7.53e-04 | 134 | 61 | 4 | GO:0003697 | |
| GeneOntologyMolecularFunction | 5S rRNA binding | 8.16e-04 | 14 | 61 | 2 | GO:0008097 | |
| GeneOntologyMolecularFunction | four-way junction DNA binding | 1.52e-03 | 19 | 61 | 2 | GO:0000400 | |
| GeneOntologyMolecularFunction | DNA binding, bending | 1.68e-03 | 20 | 61 | 2 | GO:0008301 | |
| GeneOntologyMolecularFunction | chromatin DNA binding | 1.70e-03 | 167 | 61 | 4 | GO:0031490 | |
| GeneOntologyMolecularFunction | rRNA binding | 1.82e-03 | 79 | 61 | 3 | GO:0019843 | |
| GeneOntologyBiologicalProcess | DNA recombination | 9.51e-07 | 368 | 59 | 9 | GO:0006310 | |
| GeneOntologyBiologicalProcess | DNA topological change | 2.63e-06 | 10 | 59 | 3 | GO:0006265 | |
| GeneOntologyBiologicalProcess | chromosome organization | H2BC1 H1-8 KAT5 CTCF MEIKIN H1-3 HMGB1 MSH3 GEN1 TOP2A TOP2B | 3.32e-06 | 686 | 59 | 11 | GO:0051276 |
| GeneOntologyBiologicalProcess | positive regulation of single stranded viral RNA replication via double stranded DNA intermediate | 8.04e-06 | 2 | 59 | 2 | GO:0045870 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA recombination | 1.85e-05 | 55 | 59 | 4 | GO:0045910 | |
| GeneOntologyBiologicalProcess | regulation of DNA recombination | 6.94e-05 | 150 | 59 | 5 | GO:0000018 | |
| GeneOntologyBiologicalProcess | ribonucleoprotein complex biogenesis | 1.04e-04 | 515 | 59 | 8 | GO:0022613 | |
| GeneOntologyBiologicalProcess | regulation of DNA metabolic process | 1.93e-04 | 564 | 59 | 8 | GO:0051052 | |
| GeneOntologyBiologicalProcess | chromatin organization | 2.06e-04 | 896 | 59 | 10 | GO:0006325 | |
| GeneOntologyBiologicalProcess | DNA metabolic process | 2.15e-04 | 1081 | 59 | 11 | GO:0006259 | |
| GeneOntologyBiologicalProcess | female meiosis chromosome segregation | 2.23e-04 | 8 | 59 | 2 | GO:0016321 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | 2.39e-04 | 741 | 59 | 9 | GO:0006338 | |
| GeneOntologyBiologicalProcess | chromosome condensation | 3.51e-04 | 48 | 59 | 3 | GO:0030261 | |
| GeneOntologyBiologicalProcess | translation at presynapse | 3.73e-04 | 49 | 59 | 3 | GO:0140236 | |
| GeneOntologyBiologicalProcess | ribosome biogenesis | 3.89e-04 | 336 | 59 | 6 | GO:0042254 | |
| GeneOntologyBiologicalProcess | translation at synapse | 3.96e-04 | 50 | 59 | 3 | GO:0140241 | |
| GeneOntologyBiologicalProcess | translation at postsynapse | 3.96e-04 | 50 | 59 | 3 | GO:0140242 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | 4.12e-04 | 122 | 59 | 4 | GO:0006334 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | 4.91e-04 | 999 | 59 | 10 | GO:0071824 | |
| GeneOntologyBiologicalProcess | rRNA processing | 5.06e-04 | 230 | 59 | 5 | GO:0006364 | |
| GeneOntologyCellularComponent | nucleosome | 2.77e-06 | 138 | 60 | 6 | GO:0000786 | |
| GeneOntologyCellularComponent | dense fibrillar component | 1.69e-04 | 7 | 60 | 2 | GO:0001651 | |
| GeneOntologyCellularComponent | germ cell nucleus | 3.13e-04 | 113 | 60 | 4 | GO:0043073 | |
| GeneOntologyCellularComponent | cytosolic large ribosomal subunit | 6.52e-04 | 59 | 60 | 3 | GO:0022625 | |
| Domain | DNA_topoisoIV | 9.48e-06 | 2 | 58 | 2 | PF00521 | |
| Domain | Topo_IIA_A/C_ab | 9.48e-06 | 2 | 58 | 2 | IPR013758 | |
| Domain | Topo_IIA_A_a | 9.48e-06 | 2 | 58 | 2 | IPR013757 | |
| Domain | Topo_IIA_cen_dom | 9.48e-06 | 2 | 58 | 2 | IPR013759 | |
| Domain | - | 9.48e-06 | 2 | 58 | 2 | 3.40.50.670 | |
| Domain | DTHCT | 9.48e-06 | 2 | 58 | 2 | IPR012542 | |
| Domain | TOP4c | 9.48e-06 | 2 | 58 | 2 | SM00434 | |
| Domain | TOP2c | 9.48e-06 | 2 | 58 | 2 | SM00433 | |
| Domain | Topo_IIA-like_dom | 9.48e-06 | 2 | 58 | 2 | IPR013760 | |
| Domain | Topo_IIA_bsu_dom2 | 9.48e-06 | 2 | 58 | 2 | IPR013506 | |
| Domain | DTHCT | 9.48e-06 | 2 | 58 | 2 | PF08070 | |
| Domain | DNA_gyraseB | 9.48e-06 | 2 | 58 | 2 | PF00204 | |
| Domain | - | 9.48e-06 | 2 | 58 | 2 | 1.10.268.10 | |
| Domain | TOPRIM_C | 9.48e-06 | 2 | 58 | 2 | IPR031660 | |
| Domain | TOPRIM_C | 9.48e-06 | 2 | 58 | 2 | PF16898 | |
| Domain | - | 9.48e-06 | 2 | 58 | 2 | 3.90.199.10 | |
| Domain | TopoIIA_CS | 9.48e-06 | 2 | 58 | 2 | IPR018522 | |
| Domain | Topo_IIA_A/C | 9.48e-06 | 2 | 58 | 2 | IPR002205 | |
| Domain | Topo_IIA | 9.48e-06 | 2 | 58 | 2 | IPR001241 | |
| Domain | TOPOISOMERASE_II | 9.48e-06 | 2 | 58 | 2 | PS00177 | |
| Domain | - | 2.84e-05 | 3 | 58 | 2 | 3.30.1360.40 | |
| Domain | Arg_repress_C-like | 2.84e-05 | 3 | 58 | 2 | IPR024946 | |
| Domain | Toprim_domain | 5.66e-05 | 4 | 58 | 2 | IPR006171 | |
| Domain | Toprim | 5.66e-05 | 4 | 58 | 2 | PF01751 | |
| Domain | TOPRIM | 5.66e-05 | 4 | 58 | 2 | PS50880 | |
| Domain | H15 | 7.23e-04 | 13 | 58 | 2 | SM00526 | |
| Domain | Linker_histone | 7.23e-04 | 13 | 58 | 2 | PF00538 | |
| Domain | H15 | 7.23e-04 | 13 | 58 | 2 | PS51504 | |
| Domain | Histone_H1/H5_H15 | 8.42e-04 | 14 | 58 | 2 | IPR005818 | |
| Domain | HATPase_c | 1.40e-03 | 18 | 58 | 2 | SM00387 | |
| Domain | HATPase_c | 1.57e-03 | 19 | 58 | 2 | PF02518 | |
| Domain | - | 1.74e-03 | 20 | 58 | 2 | 3.30.565.10 | |
| Domain | H2B | 1.92e-03 | 21 | 58 | 2 | SM00427 | |
| Domain | HISTONE_H2B | 1.92e-03 | 21 | 58 | 2 | PS00357 | |
| Domain | Histone_H2B | 1.92e-03 | 21 | 58 | 2 | IPR000558 | |
| Domain | - | 1.92e-03 | 21 | 58 | 2 | 3.30.230.10 | |
| Domain | HATPase_C | 1.92e-03 | 21 | 58 | 2 | IPR003594 | |
| Domain | Ribosomal_S5_D2-typ_fold_subgr | 2.10e-03 | 22 | 58 | 2 | IPR014721 | |
| Domain | Ser/Thr_kinase_AS | 4.96e-03 | 357 | 58 | 5 | IPR008271 | |
| Domain | Ribosomal_S5_D2-typ_fold | 4.99e-03 | 34 | 58 | 2 | IPR020568 | |
| Domain | S_TKc | 5.08e-03 | 359 | 58 | 5 | SM00220 | |
| Domain | PROTEIN_KINASE_ST | 5.26e-03 | 362 | 58 | 5 | PS00108 | |
| Pathway | REACTOME_MAJOR_PATHWAY_OF_RRNA_PROCESSING_IN_THE_NUCLEOLUS_AND_CYTOSOL | 1.73e-06 | 180 | 46 | 7 | MM15324 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 3.84e-06 | 10 | 46 | 3 | M7239 | |
| Pathway | REACTOME_RRNA_PROCESSING | 4.11e-06 | 205 | 46 | 7 | M27685 | |
| Pathway | BIOCARTA_DNAFRAGMENT_PATHWAY | 5.27e-06 | 11 | 46 | 3 | MM1349 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 1.25e-04 | 79 | 46 | 4 | M27191 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.35e-04 | 612 | 46 | 9 | MM15547 | |
| Pathway | REACTOME_RESPONSE_OF_EIF2AK4_GCN2_TO_AMINO_ACID_DEFICIENCY | 3.34e-04 | 102 | 46 | 4 | M29813 | |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | 3.41e-04 | 42 | 46 | 3 | M48029 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 4.47e-04 | 46 | 46 | 3 | MM14935 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | 4.70e-04 | 724 | 46 | 9 | M16843 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 5.27e-04 | 115 | 46 | 4 | MM15640 | |
| Pathway | REACTOME_NONSENSE_MEDIATED_DECAY_NMD | 5.44e-04 | 116 | 46 | 4 | M27921 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_INITIATION | 6.18e-04 | 120 | 46 | 4 | M27686 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_INITIATION | 6.78e-04 | 123 | 46 | 4 | MM15415 | |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 7.18e-04 | 54 | 46 | 3 | MM14904 | |
| Pathway | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | 7.94e-04 | 13 | 46 | 2 | M1018 | |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.16e-03 | 142 | 46 | 4 | M27233 | |
| Pathway | REACTOME_FORMATION_OF_SENESCENCE_ASSOCIATED_HETEROCHROMATIN_FOCI_SAHF | 1.37e-03 | 17 | 46 | 2 | M27189 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_STARVATION | 1.68e-03 | 157 | 46 | 4 | M41835 | |
| Pubmed | CEP350 RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 PDCD11 NOL7 NCL TEX10 RPL4 TOP2A SDAD1 | 1.30e-13 | 483 | 62 | 14 | 36912080 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | RPL22 REXO4 AFAP1 KAT5 DHX37 GLYR1 ZC3H13 EIF2S2 HMGB1 NCL UPF3A SIPA1L2 TEX10 RPL4 SF3A2 SDAD1 TOP2B HIRA | 3.30e-13 | 1082 | 62 | 18 | 38697112 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RPL22 RPL32 REXO4 DHX37 GLYR1 EIF2S2 PDCD11 NOL7 NCL TEX10 RPL4 TOP2A SDAD1 TOP2B H2BC18 | 3.80e-12 | 759 | 62 | 15 | 35915203 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | RPL22 CPNE8 RPL32 REXO4 AFAP1 DHX37 GLYR1 ZC3H13 EIF2S2 H1-3 PDCD11 HMGB1 NCL TEX10 RPL4 SF3A2 TOP2A SDAD1 | 4.02e-12 | 1257 | 62 | 18 | 36526897 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RPL22 RPL32 KAT5 HIRIP3 CTCF GLYR1 ZC3H13 PDCD11 HMGB1 NOL7 NCL MSH3 RPL4 SF3A2 TOP2A TOP2B HIRA MSL2 | 6.50e-12 | 1294 | 62 | 18 | 30804502 |
| Pubmed | PDIA4 RPL22 H2BC1 C9orf43 DGKK H1-3 ABCC5 HMGB1 NCL SIPA1L2 TEX10 MNDA RPL4 SF3A2 TOP2A TOP2B CHRNB3 H2BC18 | 3.85e-11 | 1442 | 62 | 18 | 35575683 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 PDCD11 NOL7 NCL TEX10 RPL4 SF3A2 TOP2A SDAD1 TOP2B | 1.55e-10 | 989 | 62 | 15 | 36424410 |
| Pubmed | CEP350 RPL22 RPL32 REXO4 KAT5 CTCF GLYR1 NOL7 TEX10 RPL4 TOP2A | 1.90e-10 | 417 | 62 | 11 | 36537216 | |
| Pubmed | RPL32 REXO4 CTCF DHX37 GLYR1 ZC3H13 PDCD11 NCL TEX10 RPL4 SF3A2 TOP2A SDAD1 TOP2B | 2.29e-10 | 847 | 62 | 14 | 35850772 | |
| Pubmed | RPL22 RPL32 REXO4 ZC3H13 EIF2S2 H1-3 PDCD11 NOL7 NCL TEX10 RPL4 SF3A2 TOP2A | 4.53e-10 | 731 | 62 | 13 | 29298432 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | PDIA4 RPL22 RPL32 DHX37 GLYR1 EIF2S2 H1-3 PDCD11 NOL7 NCL TEX10 RPL4 SF3A2 TOP2A | 9.94e-10 | 949 | 62 | 14 | 36574265 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | RPL22 H2BC1 REXO4 CTCF ZC3H13 EIF2S2 PDCD11 HMGB1 NOL7 NCL TOP2A TOP2B HMGB1P1 H2BC18 | 1.06e-09 | 954 | 62 | 14 | 36373674 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDIA4 RPL22 RPL32 REXO4 DHX37 GLYR1 EIF2S2 PDCD11 HMGB1 NOL7 NCL MSH3 RPL4 TOP2A SDAD1 TOP2B | 2.67e-09 | 1425 | 62 | 16 | 30948266 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | RPL22 RPL32 DHX37 ZC3H13 EIF2S2 H1-3 PDCD11 HMGB1 NOL7 NCL RPL4 SF3A2 TOP2A TOP2B H2BC18 | 7.70e-09 | 1318 | 62 | 15 | 30463901 |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | RPL22 REXO4 HEATR6 ZC3H13 EIF2S2 H1-3 PDCD11 HMGB1 NCL RPL4 SF3A2 TOP2A | 1.68e-08 | 807 | 62 | 12 | 22681889 |
| Pubmed | PDIA4 REXO4 CTCF DHX37 GLYR1 ZC3H13 H1-3 PDCD11 NCL TEX10 RPL4 | 2.01e-08 | 653 | 62 | 11 | 22586326 | |
| Pubmed | 4.61e-08 | 188 | 62 | 7 | 29721183 | ||
| Pubmed | 6.39e-08 | 425 | 62 | 9 | 21081503 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 7.06e-08 | 430 | 62 | 9 | 38172120 | |
| Pubmed | 9.62e-08 | 317 | 62 | 8 | 30997501 | ||
| Pubmed | PDIA4 RPL22 H2BC1 RPL32 CTCF GLYR1 H1-3 PDCD11 HMGB1 NCL RPL4 HMGB1P1 H2BC18 | 1.00e-07 | 1153 | 62 | 13 | 29845934 | |
| Pubmed | 1.07e-07 | 6 | 62 | 3 | 19450526 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.12e-07 | 605 | 62 | 10 | 28977666 | |
| Pubmed | GRWD1 regulates ribosomal protein L23 levels via the ubiquitin-proteasome system. | 1.39e-07 | 221 | 62 | 7 | 29991511 | |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | 2.00e-07 | 349 | 62 | 8 | 25665578 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CEP350 PDIA4 RPL22 CPNE8 BBS7 PDCD11 NOL7 NCL TEX10 SF3A2 TOP2A TOP2B | 2.22e-07 | 1024 | 62 | 12 | 24711643 |
| Pubmed | RPL22 RPL32 CTCF EIF2S2 H1-3 HMGB1 NCL UPF3A RPL4 SF3A2 TOP2A ATP5F1EP2 RPAP2 | 2.47e-07 | 1247 | 62 | 13 | 27684187 | |
| Pubmed | FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. | 3.03e-07 | 248 | 62 | 7 | 27926873 | |
| Pubmed | 3.29e-07 | 251 | 62 | 7 | 31076518 | ||
| Pubmed | 3.29e-07 | 251 | 62 | 7 | 28077445 | ||
| Pubmed | 3.47e-07 | 253 | 62 | 7 | 29911972 | ||
| Pubmed | 5.07e-07 | 713 | 62 | 10 | 29802200 | ||
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | 5.51e-07 | 271 | 62 | 7 | 32433965 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RPL22 REXO4 DHX37 GLYR1 EIF2S2 PDCD11 NCL MSH3 TEX10 RPL4 TOP2A TOP2B HIRA | 6.21e-07 | 1353 | 62 | 13 | 29467282 |
| Pubmed | 7.95e-07 | 419 | 62 | 8 | 15635413 | ||
| Pubmed | PDIA4 RPL32 REXO4 KAT5 CTCF DHX37 GLYR1 DGKK PDCD11 HMGB1 TEX10 SDAD1 HIRA | 1.14e-06 | 1429 | 62 | 13 | 35140242 | |
| Pubmed | 1.16e-06 | 601 | 62 | 9 | 33658012 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PDIA4 RPL32 CTCF CD40 HMGB1 NCL TEX10 RPL4 SF3A2 TOP2A SDAD1 TOP2B | 1.21e-06 | 1203 | 62 | 12 | 29180619 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | 1.28e-06 | 608 | 62 | 9 | 36089195 | |
| Pubmed | 1.35e-06 | 106 | 62 | 5 | 12429849 | ||
| Pubmed | STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | 1.53e-06 | 316 | 62 | 7 | 31665637 | |
| Pubmed | 1.80e-06 | 634 | 62 | 9 | 34591612 | ||
| Pubmed | RPL32 REXO4 AFAP1 KAT5 CTCF EIF2S2 PDCD11 NOL7 TEX10 SF3A2 SDAD1 HIRA MSL2 | 1.91e-06 | 1497 | 62 | 13 | 31527615 | |
| Pubmed | 1.97e-06 | 641 | 62 | 9 | 36057605 | ||
| Pubmed | 1.98e-06 | 208 | 62 | 6 | 11790298 | ||
| Pubmed | ZBTB2 protein is a new partner of the Nucleosome Remodeling and Deacetylase (NuRD) complex. | 2.04e-06 | 330 | 62 | 7 | 33301849 | |
| Pubmed | 2.13e-06 | 332 | 62 | 7 | 25693804 | ||
| Pubmed | 2.21e-06 | 212 | 62 | 6 | 23463506 | ||
| Pubmed | 2.96e-06 | 223 | 62 | 6 | 20020773 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 3.11e-06 | 678 | 62 | 9 | 30209976 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24048577 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 1309226 | ||
| Pubmed | Use of divalent metal ions in the dna cleavage reaction of human type II topoisomerases. | 3.13e-06 | 2 | 62 | 2 | 19222228 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2555055 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 1331984 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 31106979 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16091284 | ||
| Pubmed | Kinetic analysis of human topoisomerase IIalpha and beta DNA binding by surface plasmon resonance. | 3.13e-06 | 2 | 62 | 2 | 14596941 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17361331 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10095062 | ||
| Pubmed | Functional compatibility between isoform alpha and beta of type II DNA topoisomerase. | 3.13e-06 | 2 | 62 | 2 | 14996935 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 9795238 | ||
| Pubmed | The distribution of DNA topoisomerase II isoforms in differentiated adult mouse tissues. | 3.13e-06 | 2 | 62 | 2 | 8241259 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 32535049 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 1380833 | ||
| Pubmed | Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells. | 3.13e-06 | 2 | 62 | 2 | 11927602 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17182034 | ||
| Pubmed | Topoisomerase II beta interacts with cohesin and CTCF at topological domain borders. | 3.13e-06 | 2 | 62 | 2 | 27582050 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28700616 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28087392 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28472494 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 32218491 | ||
| Pubmed | Involvement of human topoisomerase II isoforms in HIV-1 reverse transcription. | 3.13e-06 | 2 | 62 | 2 | 23399433 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 30169847 | ||
| Pubmed | Enhanced processing of UVA-irradiated DNA by human topoisomerase II in living cells. | 3.13e-06 | 2 | 62 | 2 | 15044480 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17526531 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 9155056 | ||
| Pubmed | DNA topoisomerase II distribution in mouse preimplantation embryos. | 3.13e-06 | 2 | 62 | 2 | 11835579 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2556712 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16712776 | ||
| Pubmed | Active heterodimers are formed from human DNA topoisomerase II alpha and II beta isoforms. | 3.13e-06 | 2 | 62 | 2 | 8710863 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26612825 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 10473615 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 9224616 | ||
| Pubmed | DNA damage response during chromatin remodeling in elongating spermatids of mice. | 3.13e-06 | 2 | 62 | 2 | 18032420 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8299728 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22111588 | ||
| Pubmed | Roles of DNA topoisomerase II isozymes in chemotherapy and secondary malignancies. | 3.13e-06 | 2 | 62 | 2 | 17578914 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | 3.81e-06 | 695 | 62 | 9 | 23602568 | |
| Pubmed | RNF168 and USP10 regulate topoisomerase IIα function via opposing effects on its ubiquitylation. | 4.32e-06 | 18 | 62 | 3 | 27558965 | |
| Pubmed | CEP350 CPNE8 REXO4 CTCF DHX37 GLYR1 PDCD11 NOL7 NCL TEX10 ATP2B4 SDAD1 | 4.67e-06 | 1371 | 62 | 12 | 36244648 | |
| Pubmed | 4.96e-06 | 244 | 62 | 6 | 30349055 | ||
| Pubmed | 5.08e-06 | 245 | 62 | 6 | 21182205 | ||
| Pubmed | 5.24e-06 | 723 | 62 | 9 | 34133714 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 6.94e-06 | 148 | 62 | 5 | 32538781 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | 7.21e-06 | 400 | 62 | 7 | 35013556 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | 7.45e-06 | 262 | 62 | 6 | 36880596 | |
| Pubmed | 8.60e-06 | 72 | 62 | 4 | 31248990 | ||
| Pubmed | Nuclear interactions of topoisomerase II alpha and beta with phospholipid scramblase 1. | 9.37e-06 | 3 | 62 | 2 | 17567603 | |
| Pubmed | 9.37e-06 | 3 | 62 | 2 | 11136718 | ||
| Interaction | NOP56 interactions | PDIA4 RPL22 RPL32 REXO4 HIRIP3 CTCF DHX37 GLYR1 EIF2S2 H1-3 PDCD11 NCL TEX10 MNDA RPL4 TOP2A SDAD1 TOP2B | 4.37e-14 | 570 | 61 | 18 | int:NOP56 |
| Interaction | H1-4 interactions | RPL22 REXO4 HIRIP3 CTCF DHX37 GLYR1 H1-3 PDCD11 HMGB1 NCL TEX10 MNDA RPL4 SDAD1 TOP2B H2BC18 | 6.89e-11 | 656 | 61 | 16 | int:H1-4 |
| Interaction | MECP2 interactions | RPL22 RPL32 REXO4 AFAP1 KAT5 DHX37 GLYR1 ZC3H13 EIF2S2 PDCD11 HMGB1 NCL UPF3A SIPA1L2 TEX10 RPL4 SF3A2 SDAD1 TOP2B H2BC18 HIRA | 7.17e-11 | 1287 | 61 | 21 | int:MECP2 |
| Interaction | CENPA interactions | REXO4 HIRIP3 DHX37 GLYR1 ZC3H13 PDCD11 HMGB1 MSH3 TEX10 TOP2A SDAD1 TOP2B HIRA | 8.16e-11 | 377 | 61 | 13 | int:CENPA |
| Interaction | RPL31 interactions | RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 ZC3H13 H1-3 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 TOP2B | 1.17e-10 | 680 | 61 | 16 | int:RPL31 |
| Interaction | USP36 interactions | CEP350 RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 PDCD11 NOL7 NCL TEX10 MNDA RPL4 TOP2A SDAD1 | 2.09e-10 | 599 | 61 | 15 | int:USP36 |
| Interaction | RPL36 interactions | RPL22 RPL32 REXO4 CTCF GLYR1 H1-3 PDCD11 HMGB1 NCL TEX10 RPL4 ATP2B4 TOP2A SDAD1 | 2.40e-10 | 504 | 61 | 14 | int:RPL36 |
| Interaction | RPS24 interactions | RPL22 RPL32 REXO4 CTCF BBS7 DHX37 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 TOP2B | 4.51e-10 | 529 | 61 | 14 | int:RPS24 |
| Interaction | FBL interactions | RPL32 REXO4 CTCF DHX37 GLYR1 EIF2S2 CD40 PDCD11 NOL7 NCL MNDA RPL4 TOP2A SDAD1 TOP2B | 5.11e-10 | 639 | 61 | 15 | int:FBL |
| Interaction | ZNF330 interactions | RPL22 REXO4 DHX37 GLYR1 PDCD11 HMGB1 NCL MSH3 TEX10 TOP2A SDAD1 TOP2B H2BC18 | 6.42e-10 | 446 | 61 | 13 | int:ZNF330 |
| Interaction | NPM1 interactions | RPL22 PLCZ1 RPL32 REXO4 IMPG1 CTCF DHX37 GLYR1 EIF2S2 H1-3 PDCD11 HMGB1 NCL TEX10 MNDA RPL4 TOP2A SDAD1 TOP2B | 1.26e-09 | 1201 | 61 | 19 | int:NPM1 |
| Interaction | H2BC5 interactions | CEP350 PDIA4 H2BC1 H1-8 REXO4 H1-3 NCL RPL4 TOP2A H2BC18 HIRA | 4.00e-09 | 331 | 61 | 11 | int:H2BC5 |
| Interaction | SURF6 interactions | RPL22 H1-8 REXO4 CTCF DHX37 GLYR1 H1-3 PDCD11 NCL MNDA RPL4 SDAD1 | 4.66e-09 | 426 | 61 | 12 | int:SURF6 |
| Interaction | FGFBP1 interactions | 4.86e-09 | 257 | 61 | 10 | int:FGFBP1 | |
| Interaction | RPL15 interactions | RPL22 RPL32 H1-8 REXO4 CTCF EIF2S2 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 | 5.15e-09 | 530 | 61 | 13 | int:RPL15 |
| Interaction | H3C1 interactions | H2BC1 PLCZ1 RPL32 REXO4 KAT5 CTCF DHX37 GLYR1 H1-3 HMGB1 MSH3 TOP2A SDAD1 TOP2B H2BC18 HIRA | 6.83e-09 | 901 | 61 | 16 | int:H3C1 |
| Interaction | H2BC9 interactions | CEP350 H2BC1 H1-8 HIRIP3 DGKK H1-3 HMGB1 NOL7 MSH3 RPL4 TOP2A H2BC18 | 7.78e-09 | 446 | 61 | 12 | int:H2BC9 |
| Interaction | CTCF interactions | RPL22 RPL32 CTCF EIF2S2 H1-3 HMGB1 NCL MNDA RPL4 TOP2A TOP2B HIRA | 1.12e-08 | 461 | 61 | 12 | int:CTCF |
| Interaction | RPS10 interactions | RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 EIF2S2 H1-3 HMGB1 NCL RPL4 TOP2A SDAD1 | 1.15e-08 | 567 | 61 | 13 | int:RPS10 |
| Interaction | H1-5 interactions | PDIA4 C9orf43 REXO4 GLYR1 H1-3 ABCC5 HMGB1 NCL TEX10 RPL4 H2BC18 HIRA | 1.18e-08 | 463 | 61 | 12 | int:H1-5 |
| Interaction | ADARB1 interactions | RPL22 RPL32 REXO4 CTCF GLYR1 PDCD11 NCL RPL4 TOP2A SDAD1 TOP2B H2BC18 | 2.16e-08 | 489 | 61 | 12 | int:ADARB1 |
| Interaction | POLR1G interactions | REXO4 CTCF DHX37 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 TOP2B RPAP2 | 2.16e-08 | 489 | 61 | 12 | int:POLR1G |
| Interaction | RPL28 interactions | RPL22 RPL32 REXO4 CTCF GLYR1 H1-3 PDCD11 NCL SIPA1L2 RPL4 TOP2A SDAD1 | 2.41e-08 | 494 | 61 | 12 | int:RPL28 |
| Interaction | RPS16 interactions | RPL22 RPL32 CTCF DHX37 GLYR1 EIF2S2 H1-3 PDCD11 HMGB1 NCL RPL4 TOP2A SDAD1 TOP2B | 2.48e-08 | 724 | 61 | 14 | int:RPS16 |
| Interaction | ZNF668 interactions | 2.50e-08 | 226 | 61 | 9 | int:ZNF668 | |
| Interaction | H2AB2 interactions | 3.36e-08 | 107 | 61 | 7 | int:H2AB2 | |
| Interaction | KAT6A interactions | CEP350 RPL22 RPL32 REXO4 KAT5 CTCF GLYR1 NOL7 TEX10 RPL4 TOP2A H2BC18 | 3.42e-08 | 510 | 61 | 12 | int:KAT6A |
| Interaction | RPS6 interactions | RPL22 RPL32 H1-8 REXO4 CTCF DHX37 GLYR1 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 TOP2B | 3.49e-08 | 874 | 61 | 15 | int:RPS6 |
| Interaction | ZC3H18 interactions | RPL22 RPL32 REXO4 CTCF ZC3H13 EIF2S2 H1-3 PDCD11 HMGB1 NOL7 NCL TEX10 RPL4 SF3A2 TOP2A | 3.65e-08 | 877 | 61 | 15 | int:ZC3H18 |
| Interaction | RPL8 interactions | RPL22 RPL32 H1-8 REXO4 HIRIP3 CTCF GLYR1 PDCD11 HMGB1 NCL RPL4 TOP2A | 6.27e-08 | 539 | 61 | 12 | int:RPL8 |
| Interaction | MYCN interactions | RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 ZC3H13 EIF2S2 PDCD11 HMGB1 NOL7 NCL TEX10 RPL4 SF3A2 SDAD1 H2BC18 RPAP2 | 7.03e-08 | 1373 | 61 | 18 | int:MYCN |
| Interaction | RRP8 interactions | 8.06e-08 | 259 | 61 | 9 | int:RRP8 | |
| Interaction | RPL18A interactions | RPL22 RPL32 REXO4 CTCF GLYR1 PDCD11 HMGB1 NCL TEX10 RPL4 SDAD1 | 8.71e-08 | 447 | 61 | 11 | int:RPL18A |
| Interaction | HBP1 interactions | 8.82e-08 | 123 | 61 | 7 | int:HBP1 | |
| Interaction | NPM3 interactions | 8.89e-08 | 262 | 61 | 9 | int:NPM3 | |
| Interaction | RPL35 interactions | RPL22 PLCZ1 RPL32 REXO4 CTCF GLYR1 HMGB1 NCL RPL4 TOP2A SDAD1 TOP2B | 9.13e-08 | 558 | 61 | 12 | int:RPL35 |
| Interaction | MNDA interactions | 9.54e-08 | 188 | 61 | 8 | int:MNDA | |
| Interaction | RPL13 interactions | RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 | 1.35e-07 | 700 | 61 | 13 | int:RPL13 |
| Interaction | ZC3H10 interactions | 1.54e-07 | 200 | 61 | 8 | int:ZC3H10 | |
| Interaction | SRSF5 interactions | RPL32 REXO4 CTCF DHX37 GLYR1 H1-3 HMGB1 NCL RPL4 SF3A2 H2BC18 | 1.57e-07 | 474 | 61 | 11 | int:SRSF5 |
| Interaction | HECTD1 interactions | RPL22 RPL32 REXO4 DHX37 GLYR1 EIF2S2 PDCD11 NOL7 NCL TEX10 RPL4 TOP2A SDAD1 TOP2B H2BC18 | 1.64e-07 | 984 | 61 | 15 | int:HECTD1 |
| Interaction | IFI16 interactions | PDIA4 REXO4 CTCF DHX37 GLYR1 H1-3 PDCD11 NCL TEX10 RPL4 TOP2A SDAD1 TOP2B | 1.70e-07 | 714 | 61 | 13 | int:IFI16 |
| Interaction | RPL3 interactions | RPL22 RPL32 H1-8 REXO4 CTCF GLYR1 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 | 1.93e-07 | 722 | 61 | 13 | int:RPL3 |
| Interaction | LLPH interactions | 2.04e-07 | 139 | 61 | 7 | int:LLPH | |
| Interaction | RPL10A interactions | RPL22 RPL32 REXO4 CTCF GLYR1 MEIKIN HMGB1 NCL RPL4 TOP2A H2BC18 | 2.19e-07 | 490 | 61 | 11 | int:RPL10A |
| Interaction | PARP1 interactions | RPL22 H2BC1 C9orf43 REXO4 CTCF DHX37 GLYR1 EIF2S2 H1-3 PDCD11 HMGB1 NCL MSH3 TEX10 TOP2A SDAD1 TOP2B | 2.21e-07 | 1316 | 61 | 17 | int:PARP1 |
| Interaction | MACROH2A2 interactions | 2.31e-07 | 211 | 61 | 8 | int:MACROH2A2 | |
| Interaction | C7orf50 interactions | 2.97e-07 | 218 | 61 | 8 | int:C7orf50 | |
| Interaction | ZNF48 interactions | 3.27e-07 | 149 | 61 | 7 | int:ZNF48 | |
| Interaction | ILF3 interactions | PDIA4 RPL22 RPL32 REXO4 CTCF GLYR1 EIF2S2 H1-3 PDCD11 NCL TEX10 RPL4 SF3A2 TOP2A | 3.41e-07 | 896 | 61 | 14 | int:ILF3 |
| Interaction | RPS14 interactions | RPL22 RPL32 H1-8 REXO4 CTCF PDCD11 HMGB1 NCL RPL4 TOP2A SDAD1 | 4.69e-07 | 529 | 61 | 11 | int:RPS14 |
| Interaction | HMGA1 interactions | 4.75e-07 | 419 | 61 | 10 | int:HMGA1 | |
| Interaction | RPS3A interactions | RPL22 H2BC1 RPL32 REXO4 CTCF DHX37 GLYR1 HMGB1 NCL RPL4 TOP2A H2BC18 | 5.09e-07 | 655 | 61 | 12 | int:RPS3A |
| Interaction | RPLP0 interactions | RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 PDCD11 HMGB1 NCL TEX10 RPL4 SDAD1 | 5.52e-07 | 660 | 61 | 12 | int:RPLP0 |
| Interaction | NIFK interactions | 6.14e-07 | 431 | 61 | 10 | int:NIFK | |
| Interaction | DDRGK1 interactions | RPL22 RPL32 REXO4 CTCF DHX37 GLYR1 EIF2S2 H1-3 PDCD11 HMGB1 NCL TEX10 RPL4 TOP2A SDAD1 H2BC18 | 6.14e-07 | 1249 | 61 | 16 | int:DDRGK1 |
| Interaction | SRP72 interactions | 6.72e-07 | 333 | 61 | 9 | int:SRP72 | |
| Interaction | LHX1 interactions | 6.80e-07 | 103 | 61 | 6 | int:LHX1 | |
| Interaction | RPL22 interactions | 7.41e-07 | 440 | 61 | 10 | int:RPL22 | |
| Interaction | LARP7 interactions | RPL22 H2BC1 RPL32 REXO4 CTCF DHX37 H1-3 PDCD11 HMGB1 NCL MNDA RPL4 SF3A2 HMGB1P1 H2BC18 | 7.91e-07 | 1113 | 61 | 15 | int:LARP7 |
| Interaction | RRS1 interactions | 9.01e-07 | 345 | 61 | 9 | int:RRS1 | |
| Interaction | PUM3 interactions | 9.43e-07 | 254 | 61 | 8 | int:PUM3 | |
| Interaction | MAGEB2 interactions | 9.92e-07 | 349 | 61 | 9 | int:MAGEB2 | |
| Interaction | RPL17 interactions | RPL22 RPL32 H1-8 REXO4 CTCF GLYR1 PDCD11 HMGB1 NCL RPL4 TOP2A | 9.93e-07 | 571 | 61 | 11 | int:RPL17 |
| Interaction | H2BC8 interactions | REXO4 KAT5 HIRIP3 CTCF DHX37 GLYR1 MSH3 TEX10 TOP2A TOP2B H2BC18 | 1.08e-06 | 576 | 61 | 11 | int:H2BC8 |
| Interaction | SMC5 interactions | RPL22 H2BC1 REXO4 CTCF ZC3H13 EIF2S2 PDCD11 HMGB1 NOL7 NCL TOP2A TOP2B HMGB1P1 H2BC18 | 1.27e-06 | 1000 | 61 | 14 | int:SMC5 |
| Interaction | SRPK2 interactions | RPL22 RPL32 REXO4 HIRIP3 CTCF GLYR1 ZC3H13 PDCD11 NCL RPL4 TOP2A TOP2B | 1.32e-06 | 717 | 61 | 12 | int:SRPK2 |
| Interaction | RPL13A interactions | RPL22 RPL32 H1-8 REXO4 CTCF GLYR1 PDCD11 HMGB1 NCL RPL4 SDAD1 | 1.39e-06 | 591 | 61 | 11 | int:RPL13A |
| Interaction | RBM8A interactions | 1.42e-06 | 473 | 61 | 10 | int:RBM8A | |
| Interaction | H2AX interactions | PDIA4 H2BC1 REXO4 KAT5 HIRIP3 CTCF EIF2S2 NCL MNDA RPL4 H2BC18 | 1.44e-06 | 593 | 61 | 11 | int:H2AX |
| Interaction | RPL30 interactions | 1.45e-06 | 474 | 61 | 10 | int:RPL30 | |
| Interaction | DDX23 interactions | 1.63e-06 | 480 | 61 | 10 | int:DDX23 | |
| Interaction | MEN1 interactions | RPL32 REXO4 CTCF DHX37 GLYR1 ZC3H13 PDCD11 TEX10 RPL4 SF3A2 TOP2A SDAD1 TOP2B HIRA | 1.78e-06 | 1029 | 61 | 14 | int:MEN1 |
| Interaction | HMGB1 interactions | 1.82e-06 | 486 | 61 | 10 | int:HMGB1 | |
| Interaction | NSD2 interactions | 1.85e-06 | 278 | 61 | 8 | int:NSD2 | |
| Interaction | SIRT7 interactions | PDIA4 REXO4 CTCF DHX37 GLYR1 ZC3H13 H1-3 PDCD11 NCL TEX10 RPL4 TOP2A | 1.94e-06 | 744 | 61 | 12 | int:SIRT7 |
| Interaction | SRP68 interactions | 2.04e-06 | 381 | 61 | 9 | int:SRP68 | |
| Interaction | GRWD1 interactions | 2.48e-06 | 390 | 61 | 9 | int:GRWD1 | |
| Interaction | RPL37A interactions | 2.53e-06 | 391 | 61 | 9 | int:RPL37A | |
| Interaction | RBM34 interactions | 2.54e-06 | 290 | 61 | 8 | int:RBM34 | |
| Interaction | H1-3 interactions | 2.60e-06 | 291 | 61 | 8 | int:H1-3 | |
| Interaction | H2AC4 interactions | 2.61e-06 | 506 | 61 | 10 | int:H2AC4 | |
| Interaction | NR2C2 interactions | RPL22 RPL32 DHX37 ZC3H13 EIF2S2 H1-3 PDCD11 HMGB1 NOL7 NCL RPL4 SF3A2 TOP2A TOP2B H2BC18 HIRA | 2.84e-06 | 1403 | 61 | 16 | int:NR2C2 |
| Interaction | RPL24 interactions | 2.86e-06 | 397 | 61 | 9 | int:RPL24 | |
| Interaction | RPS19 interactions | RPL22 RPL32 REXO4 CTCF GLYR1 EIF2S2 H1-3 HMGB1 NCL RPL4 SDAD1 | 2.96e-06 | 639 | 61 | 11 | int:RPS19 |
| Interaction | H3C15 interactions | 2.97e-06 | 207 | 61 | 7 | int:H3C15 | |
| Interaction | PRKRA interactions | 3.04e-06 | 400 | 61 | 9 | int:PRKRA | |
| Interaction | H2BC13 interactions | 3.27e-06 | 210 | 61 | 7 | int:H2BC13 | |
| Interaction | H2AB3 interactions | 3.46e-06 | 136 | 61 | 6 | int:H2AB3 | |
| Interaction | IL17B interactions | 3.83e-06 | 78 | 61 | 5 | int:IL17B | |
| Interaction | RPS2 interactions | RPL22 RPL32 CTCF DHX37 GLYR1 H1-3 HMGB1 NCL TEX10 RPL4 TOP2A | 3.86e-06 | 657 | 61 | 11 | int:RPS2 |
| Interaction | NOP2 interactions | 4.19e-06 | 416 | 61 | 9 | int:NOP2 | |
| Interaction | H1-2 interactions | PDIA4 RPL22 H1-8 REXO4 GLYR1 H1-3 PDCD11 NCL MAP3K21 MNDA H2BC18 | 4.39e-06 | 666 | 61 | 11 | int:H1-2 |
| Interaction | DOT1L interactions | RPL32 REXO4 CTCF GLYR1 ZC3H13 PDCD11 NCL TEX10 SF3A2 TOP2A SDAD1 TOP2B | 4.48e-06 | 807 | 61 | 12 | int:DOT1L |
| Interaction | RBM19 interactions | 4.58e-06 | 221 | 61 | 7 | int:RBM19 | |
| Interaction | PURG interactions | 4.86e-06 | 223 | 61 | 7 | int:PURG | |
| Interaction | SRP9 interactions | 5.17e-06 | 427 | 61 | 9 | int:SRP9 | |
| Interaction | RPL7A interactions | RPL22 RPL32 H1-8 C9orf43 REXO4 CTCF GLYR1 HMGB1 NCL RPL4 H2BC18 | 5.28e-06 | 679 | 61 | 11 | int:RPL7A |
| Interaction | PRC1 interactions | RPL22 H2BC1 RPL32 AFAP1 CTCF GLYR1 H1-3 PDCD11 NCL RPL4 SF3A2 TOP2A TOP2B | 5.42e-06 | 973 | 61 | 13 | int:PRC1 |
| Interaction | H2BC12 interactions | 5.49e-06 | 322 | 61 | 8 | int:H2BC12 | |
| Cytoband | 13q12 | 4.86e-04 | 24 | 62 | 2 | 13q12 | |
| GeneFamily | Topoisomerases | 7.86e-05 | 6 | 42 | 2 | 1050 | |
| GeneFamily | Histones | 1.49e-04 | 116 | 42 | 4 | 864 | |
| GeneFamily | L ribosomal proteins | 2.25e-04 | 51 | 42 | 3 | 729 | |
| Coexpression | RICKMAN_METASTASIS_UP | 1.33e-07 | 350 | 62 | 9 | M9752 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | 6.69e-07 | 555 | 62 | 10 | M2343 | |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.37e-06 | 90 | 62 | 5 | M39250 | |
| Coexpression | BUSSLINGER_DUODENAL_TRANSIT_AMPLIFYING_CELLS | 6.63e-06 | 194 | 62 | 6 | M40026 | |
| Coexpression | GSE20152_SPHK1_KO_VS_HTNFA_OVEREXPRESS_ANKLE_DN | 7.24e-06 | 197 | 62 | 6 | M7683 | |
| Coexpression | TABULA_MURIS_SENIS_MARROW_ERYTHROBLAST_AGEING | 8.59e-06 | 203 | 62 | 6 | MM3795 | |
| Coexpression | BUSSLINGER_DUODENAL_STEM_CELLS | 8.70e-06 | 311 | 62 | 7 | M40024 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_UP | 1.31e-05 | 612 | 62 | 9 | M4772 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_3DY_NEGATIVE | RPL32 C9orf43 HIRIP3 EIF2S2 CDKL3 PDCD11 ABCC5 SDAD1 ATP5F1EP2 | 1.80e-05 | 637 | 62 | 9 | M41118 |
| Coexpression | BUSSLINGER_ESOPHAGEAL_PROLIFERATING_BASAL_CELLS | 2.31e-05 | 70 | 62 | 4 | M40002 | |
| Coexpression | BUSSLINGER_ESOPHAGEAL_EARLY_SUPRABASAL_CELLS | 3.73e-05 | 79 | 62 | 4 | M40003 | |
| Coexpression | BUSSLINGER_DUODENAL_DIFFERENTIATING_STEM_CELLS | 8.40e-05 | 305 | 62 | 6 | M40025 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_EFF_MEMORY_CD4_TCELL_DN | 1.07e-04 | 198 | 62 | 5 | M5417 | |
| Coexpression | GAUCHER_PBMC_YF_VAX_STAMARIL_UNKNOWN_AGE_3DY_DN | 1.09e-04 | 104 | 62 | 4 | M41147 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 1.12e-04 | 200 | 62 | 5 | M9439 | |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_DN | 1.12e-04 | 200 | 62 | 5 | M8037 | |
| Coexpression | GSE360_DC_VS_MAC_L_DONOVANI_DN | 1.12e-04 | 200 | 62 | 5 | M5176 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 1.12e-04 | 200 | 62 | 5 | M7841 | |
| Coexpression | ZAK_PBMC_MRKAD5_HIV_1_GAG_POL_NEF_AGE_20_50YO_1DY_DN | 1.22e-04 | 1012 | 62 | 10 | M40864 | |
| Coexpression | TABULA_MURIS_SENIS_HEART_AND_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | 1.23e-04 | 327 | 62 | 6 | MM3714 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 1.38e-04 | 481 | 62 | 7 | M3898 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | 1.52e-04 | 656 | 62 | 8 | M18979 | |
| Coexpression | MODY_HIPPOCAMPUS_PRENATAL | 1.67e-04 | 45 | 62 | 3 | M5316 | |
| Coexpression | TRAVAGLINI_LUNG_PROLIFERATING_BASAL_CELL | 2.35e-04 | 891 | 62 | 9 | M41654 | |
| Coexpression | TABULA_MURIS_SENIS_THYMUS_THYMOCYTE_AGEING | 2.38e-04 | 701 | 62 | 8 | MM3849 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_UP | 2.93e-04 | 384 | 62 | 6 | M1865 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 6.03e-05 | 780 | 60 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 | RPL22 ZC3H13 DTX4 DGKK EIF2S2 PDCD11 NCL TEX10 GEN1 TOP2A SDAD1 H2BC18 NUAK2 | 7.97e-05 | 1347 | 60 | 13 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500 |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 | RPL22 ZC3H13 DTX4 DGKK EIF2S2 PDCD11 NCL TEX10 GEN1 TOP2A SDAD1 H2BC18 | 8.43e-05 | 1164 | 60 | 12 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.02e-04 | 831 | 60 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.23e-04 | 90 | 60 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | RPL22 H2BC1 EIF2S2 CD40 H1-3 PDCD11 NCL TEX10 GEN1 SF3A2 SDAD1 H2BC18 NUAK2 | 1.45e-04 | 1429 | 60 | 13 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K3 | REXO4 DHX37 GLYR1 DGKK H1-3 PDCD11 NCL TEX10 GEN1 SF3A2 SDAD1 HIRA | 1.77e-04 | 1259 | 60 | 12 | facebase_RNAseq_e9.5_MandArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.42e-04 | 311 | 60 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.77e-04 | 204 | 60 | 5 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 186 | 61 | 6 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.12e-07 | 186 | 61 | 6 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-Lgr5+_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-07 | 192 | 61 | 6 | 5155f746ad57122ef735da776c96721005b8dadc | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.24e-07 | 200 | 61 | 6 | b340b6acf675c75adffb98e560080f966571f594 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-06 | 181 | 61 | 5 | d909821355f4bc9e35387cda6ecf7c56793d9da4 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-06 | 181 | 61 | 5 | 52935c496b45207a173b5ac7812f46210c3f74b0 | |
| ToppCell | Lymphoid-Lymphoid-T_cells_(cycle)|Lymphoid / shred on cell class and cell subclass (v4) | 4.94e-06 | 181 | 61 | 5 | b6b41cd5d43543fe7a093033dae52a789199db0e | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.64e-06 | 186 | 61 | 5 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | E15.5|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.58e-06 | 192 | 61 | 5 | 4a0fb4ef8a9281489ffb0881421c9d691c52019c | |
| ToppCell | droplet-Large_Intestine-COLON:P+D-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-06 | 192 | 61 | 5 | 448b71c965e1b7addc6bccbcd6047cefda3d5b5a | |
| ToppCell | ASK440-Endothelial-Lymphatic|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.28e-06 | 196 | 61 | 5 | 833723c8753922374cd7730907f1596899dd5734 | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-GMP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.46e-06 | 197 | 61 | 5 | 462e91dc51e363d64e1e02d7444a733838e032a5 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 7.46e-06 | 197 | 61 | 5 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.64e-06 | 198 | 61 | 5 | 5024d43b4cf7dea305ed911f1e123ca7fd44e990 | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.64e-06 | 198 | 61 | 5 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.83e-06 | 199 | 61 | 5 | 4366ead68736ae3a2cefac71fd349d526cccb611 | |
| ToppCell | Transverse-Dendritic_cell-cycling_DCs|Dendritic_cell / Region, Cell class and subclass | 8.02e-06 | 200 | 61 | 5 | 617a6a42f7b31eb3c45bdceaf55a591b6de7f154 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular|TCGA-Stomach / Sample_Type by Project: Shred V9 | 3.86e-05 | 138 | 61 | 4 | 93497c0a5d5e54006653b2dedc7a7041e1a613e6 | |
| ToppCell | (03)_Secretory-(3)_72hpi|(03)_Secretory / shred by cell type and Timepoint | 6.54e-05 | 158 | 61 | 4 | 20563d03183b63aafc9c389f3f03781140702249 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.70e-05 | 159 | 61 | 4 | 999f30c7273ed77b34537621bcfcc7fc30121138 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.55e-05 | 164 | 61 | 4 | 72ef807895385ba23e30d19d12b1b0549a699690 | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.73e-05 | 165 | 61 | 4 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-classical_monocyte-Classical_monocytes-Classical_monocytes_L.1.2.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.68e-05 | 170 | 61 | 4 | cf22a843ae2d9cd6693507fed2b7c6a45abea10e | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 173 | 61 | 4 | a5172dee859bf6c2eed46c48bd64dfef0ff9f28f | |
| ToppCell | facs-Large_Intestine-Distal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.29e-05 | 173 | 61 | 4 | 639b5b0b33ce5aa0bc26363c059717012ddc14c0 | |
| ToppCell | PND28-Immune-Immune_Lymphocytic_T/NK|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-05 | 174 | 61 | 4 | 76694cd8a1162047a9ee60521ce84201b4378a47 | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.50e-05 | 174 | 61 | 4 | cfb4947caf7b1a856df246023fc6e5bfcc97ad36 | |
| ToppCell | P03-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.04e-04 | 178 | 61 | 4 | 7975bf0a3146ee0efa4f547af5977e6bf0ba71fd | |
| ToppCell | C_00|World / shred on cell type and cluster | 1.06e-04 | 179 | 61 | 4 | da2dadc3266ffebd4a34ac61bfa05fddcadcde4c | |
| ToppCell | COVID-19_Convalescent-PLT_1|World / Disease Group and Platelet Clusters | 1.06e-04 | 179 | 61 | 4 | d0f2764c6fc5d61fd69e9231b3603a80ac373f65 | |
| ToppCell | droplet-Limb_Muscle-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.06e-04 | 179 | 61 | 4 | 013818e173101efca7625ccd4258e60655815d73 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 181 | 61 | 4 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 181 | 61 | 4 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | droplet-Spleen-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 181 | 61 | 4 | 14a04d8d69d3054b6ed3370d361dec5303ca4831 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 182 | 61 | 4 | 01ae44b465e509b0aa75ccf61bd9bc0a89d6758c | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 183 | 61 | 4 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-04 | 183 | 61 | 4 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.18e-04 | 184 | 61 | 4 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.18e-04 | 184 | 61 | 4 | e93633d89a9c54c8d2819f56372815b4ca149f06 | |
| ToppCell | facs-Thymus-Flowthrough|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.20e-04 | 185 | 61 | 4 | c0587b32f9925052016a06422ddcdc2ad9b7fc93 | |
| ToppCell | Control|World / Disease group, lineage and cell class | 1.20e-04 | 185 | 61 | 4 | 7e8add6ca19067cf451a603a3506b83e7dc3b615 | |
| ToppCell | metastatic_Brain-T/NK_cells-Naive_CD4+_T|T/NK_cells / Location, Cell class and cell subclass | 1.20e-04 | 185 | 61 | 4 | 2eee26c28b130be6163f27bc608384c054238501 | |
| ToppCell | facs-Thymus-Flowthrough-24m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 186 | 61 | 4 | 202e1514954a5a654f7588bed72cd12db513bb19 | |
| ToppCell | PBMC-Control|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.25e-04 | 187 | 61 | 4 | 91464e5b7fa5cca7810b45f41b933d3a5a6e3c95 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 187 | 61 | 4 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | NS-critical-d_16-33-Lymphoid-NKT|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.25e-04 | 187 | 61 | 4 | dda43cc4983f1c11a2258bbce9f805db4125322c | |
| ToppCell | facs-Thymus-Flowthrough-24m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 187 | 61 | 4 | 376a95ac1e38f61f8db5d23d9a905f8dae8c40b6 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.25e-04 | 187 | 61 | 4 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | PBMC-Control|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.25e-04 | 187 | 61 | 4 | b38017ffc87fb04d4e4d3755f729f9c1470bb001 | |
| ToppCell | MatrixFB-Fibroblast-E_(Early_Fibroblastic_progenitor)|MatrixFB / shred on cell class and cell subclass (v4) | 1.28e-04 | 188 | 61 | 4 | b240ea20750ffb825cb5fe41d06c632233406ab6 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 188 | 61 | 4 | 8b1485e63cd4020ba5334a8d4b84725b164549bf | |
| ToppCell | facs-Thymus-Flowthrough-3m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 188 | 61 | 4 | 59b71462338a7efbacf46577cb07e9db3363afee | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 190 | 61 | 4 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 1.33e-04 | 190 | 61 | 4 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.33e-04 | 190 | 61 | 4 | 4288189e3a499c395896c950598810b02f401685 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 1.36e-04 | 191 | 61 | 4 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | metastatic_Brain-B_lymphocytes-Follicular_B_cells|metastatic_Brain / Location, Cell class and cell subclass | 1.36e-04 | 191 | 61 | 4 | f400fce79aacf029e20b6dca59d3e17bb2375f28 | |
| ToppCell | Control|World / Disease condition and Cell class | 1.36e-04 | 191 | 61 | 4 | 17bc87bc638fd98defdaec908300728dd76b0e8c | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality-16|World / Primary Cells by Cluster | 1.39e-04 | 192 | 61 | 4 | 0d6413df15dfecdffc777fb02df3aaf0c30540b1 | |
| ToppCell | E12.5-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.39e-04 | 192 | 61 | 4 | 7953a35f7722609d0b197002c8f90fbb156db61b | |
| ToppCell | Non-neuronal-Dividing-Radial_Glia-Low_Quality|World / Primary Cells by Cluster | 1.39e-04 | 192 | 61 | 4 | 5fa5b2f250ec5ad5a232c022266f0cd01ff4a753 | |
| ToppCell | control-Lymphocytic-B_cells_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.39e-04 | 192 | 61 | 4 | f1ada2fb7f08d82c00bca2023481d975b0c2526f | |
| ToppCell | tumor_Lung-B_lymphocytes-Follicular_B_cells|tumor_Lung / Location, Cell class and cell subclass | 1.41e-04 | 193 | 61 | 4 | d0cb4bfc11491c903cb4cc0f823dd1ee239cf5c4 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 13282e849b11f48085f0840d112a06e896b32cd7 | |
| ToppCell | droplet-Tongue-Unstain-18m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.41e-04 | 193 | 61 | 4 | 63205026e20cf2c7bfb7d08bba48d5df7976ccca | |
| ToppCell | (10)_Ciliated-(0)_Reference|(10)_Ciliated / shred by cell type by condition | 1.44e-04 | 194 | 61 | 4 | f9d5bf6baddbd88947e6a740805962109649ed3b | |
| ToppCell | COVID-19_Severe-B_intermediate|COVID-19_Severe / disease group, cell group and cell class | 1.44e-04 | 194 | 61 | 4 | 3418308da7f1278ae2bf3fb61fc361b222e30043 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-basal_cell|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.44e-04 | 194 | 61 | 4 | 1eef012e53e43c4f4f6968baac3cc28727c4a9b5 | |
| ToppCell | critical-Lymphoid-NKT|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.44e-04 | 194 | 61 | 4 | 6d47bb99157943fd1283f2e1bfa163ebe08c5a26 | |
| ToppCell | B_cell_maturation-Naive_B_cell|B_cell_maturation / Lineage and Cell class | 1.44e-04 | 194 | 61 | 4 | adb6f9aff65276e0db1f8367149998938b8e4fb0 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.47e-04 | 195 | 61 | 4 | 4e114f6399863406bd87220dea7fb7dfd08824bd | |
| ToppCell | 356C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.47e-04 | 195 | 61 | 4 | ba8b8831bd5f544f4e25f13949d04e164ecdcd12 | |
| ToppCell | Mild/Remission-B_memory-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.47e-04 | 195 | 61 | 4 | 3c51f005d8546c570752f5f0ce6b8ac242d3c54b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-04 | 195 | 61 | 4 | db1660ce74819cd816bdcfcae5efb3aad82cce66 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_conv|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.47e-04 | 195 | 61 | 4 | 67ea0d48a31feed886e356a71740981b64f4d658 | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.47e-04 | 195 | 61 | 4 | 8cd7667a65d77dd7b301090a9b65aba254741375 | |
| ToppCell | droplet-Bladder-Unstain-18m-Epithelial-basal_bladder_epithelial_cell_(Krt5+Krt14+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 195 | 61 | 4 | f7a4ce7076148389471678bcc5349df8b72b653e | |
| ToppCell | NS-critical-LOC-Lymphoid-NKT|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-04 | 195 | 61 | 4 | 217e9b096a11adf84400d17403289bee7b351c42 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-04 | 195 | 61 | 4 | 97b2ff072cc830a4a2cb217f5a215ca6cad505ec | |
| ToppCell | normal_Lung-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.47e-04 | 195 | 61 | 4 | 2a9a2b36a9a4ce72a3b855c0872214f38a7c64b0 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-basal_cell_of_epidermis|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-04 | 195 | 61 | 4 | a31a8c0e8e666acfc6737fa2c54ebd6f35605520 | |
| ToppCell | PBMC|World / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.47e-04 | 195 | 61 | 4 | 211eba45a502b961873ca2d4642f7852e6e89d7a | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.47e-04 | 195 | 61 | 4 | f2693586c9e3c2ad1b5776f319b0b60e0c19628e | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD163+CD14+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 1.47e-04 | 195 | 61 | 4 | a04ddf1f191fd814e67fb28503096e1a07ccb79a | |
| ToppCell | normal_Pleural_Fluid|World / Location, Cell class and cell subclass | 1.50e-04 | 196 | 61 | 4 | 7029c9f4a826f6cfdcb5f7a472fba94e8945a771 | |
| ToppCell | (2)_B_cells-(2)_B_cells|(2)_B_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.50e-04 | 196 | 61 | 4 | 7b7338b9caeb05b78f4c88a89d41b4bece0b2bab | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-04 | 196 | 61 | 4 | 2e818e0dae640bf398bbbb0081ffa86297adc1c5 | |
| ToppCell | moderate-Lymphoid-NKT|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.50e-04 | 196 | 61 | 4 | 12232b12bb6c7c993b3f81ce370517117e45a831 | |
| ToppCell | normal_Pleural_Fluid-B_lymphocytes-Follicular_B_cells|B_lymphocytes / Location, Cell class and cell subclass | 1.50e-04 | 196 | 61 | 4 | d9951569068ad346a0764fe3bafff43e9f409992 | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-NKT|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.50e-04 | 196 | 61 | 4 | ea994e1d579b35877f0924404d31d55a940ec19b | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.50e-04 | 196 | 61 | 4 | 1b06639b7d2b81a1e5bcc455f3adda039f42ba57 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG-RG|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-04 | 196 | 61 | 4 | 0364a75fb831a9bb43d3b3c9ca1d890f9a68d6ca | |
| ToppCell | Mild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.50e-04 | 196 | 61 | 4 | 71603a3b7df40eb3f267345f55e44a812fea7926 | |
| ToppCell | COVID-19-Epithelial_cells-Cycling_epithelial|COVID-19 / group, cell type (main and fine annotations) | 1.50e-04 | 196 | 61 | 4 | ac55fff652bad06eab502645bf64126625763ab3 | |
| ToppCell | 10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-GMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.50e-04 | 196 | 61 | 4 | 3cf73b33330b9fca5c8abf03f2f0d8244245b522 | |
| ToppCell | E12.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.50e-04 | 196 | 61 | 4 | 62b2de1d38a99ab23211bf51595845f8a1fdb7d2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-RG|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.50e-04 | 196 | 61 | 4 | eb9ccc90012069b55ca92fadeb54c5f9468e937a | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.53e-04 | 197 | 61 | 4 | af022eadcd13b01230f7911f10706b5ebc7bab01 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.53e-04 | 197 | 61 | 4 | 853162b116f808dccc295cbab83b0ba98d23b006 | |
| ToppCell | severe-unassigned|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.53e-04 | 197 | 61 | 4 | 70704b149b2820b8601d2495b7cd9cbe91eda262 | |
| Computational | Neighborhood of ST13 | 5.21e-05 | 64 | 35 | 4 | GNF2_ST13 | |
| Computational | Neighborhood of FBL | 1.01e-04 | 146 | 35 | 5 | GNF2_FBL | |
| Drug | Dexrazoxane | 6.83e-06 | 2 | 60 | 2 | DB00380 | |
| Drug | F14512 | 6.83e-06 | 2 | 60 | 2 | ctd:C534191 | |
| Drug | Daunorubicin | 6.83e-06 | 2 | 60 | 2 | DB00694 | |
| Drug | NSC-629231 | 1.34e-05 | 55 | 60 | 4 | CID000363885 | |
| Disease | B cell deficiency (implicated_via_orthology) | 3.67e-06 | 2 | 57 | 2 | DOID:2115 (implicated_via_orthology) | |
| Disease | erythrocyte measurement | 1.39e-04 | 257 | 57 | 5 | EFO_0005047 | |
| Disease | Dental enamel hypoplasia | 2.39e-04 | 12 | 57 | 2 | EFO_1001304 | |
| Disease | acute myeloid leukemia (implicated_via_orthology) | 2.39e-04 | 12 | 57 | 2 | DOID:9119 (implicated_via_orthology) | |
| Disease | atherosclerosis (biomarker_via_orthology) | 6.81e-04 | 20 | 57 | 2 | DOID:1936 (biomarker_via_orthology) | |
| Disease | Nystagmus | 7.52e-04 | 21 | 57 | 2 | HP_0000639 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PVVKGKVLEKKKQKQ | 366 | Q05901 | |
| KFKFKGTNVKTKVPL | 681 | Q8IWZ6 | |
| KIKKKGVKKTFQCEL | 256 | P49711 | |
| RVTVKGFFVKKKEKK | 31 | H3BNL8 | |
| GKKITKIISLGKKKP | 321 | Q8N556 | |
| KKPKEIKVRVIKVKG | 351 | Q8IVW4 | |
| KKQAKKGKTPEEVLK | 381 | Q9Y2E6 | |
| SKGVKLVRKKKKIPG | 21 | Q8N7E2 | |
| AVKVPKKEKSVLQGK | 341 | P23634 | |
| KKTSGNSVKIVKVKK | 36 | Q5VTU8 | |
| PKKGSKKAVTKVQKK | 11 | Q5QNW6 | |
| PVKKKVKKVQQKEGG | 96 | P20585 | |
| RLKIKFPKLGKKKVE | 1216 | Q5KSL6 | |
| GKVKKAAKRPAKVQK | 171 | Q8IZA3 | |
| GYKGKTRKKPVVKKQ | 166 | Q9BW71 | |
| KTYIPPKGETKKKFK | 76 | P09429 | |
| QKIFKKLPGFKKIHV | 271 | Q17R60 | |
| KKIQFPKKEAKTPTK | 66 | Q92993 | |
| KGKKVKKQPNSILKE | 481 | Q6P5Q4 | |
| KDLKKPRGKKCFFVK | 31 | Q49A26 | |
| KKKSKVKPKKIQQGE | 316 | Q6AI08 | |
| VKNKGVIVKKKKYSL | 346 | A0A087WXM9 | |
| AVGVKKQKKPLVGKK | 386 | P36578 | |
| KQKKPLVGKKAAATK | 391 | P36578 | |
| LGNKKKKKKNVKFPD | 121 | P20042 | |
| SKTKPGILKKDKAVK | 421 | Q9HCI7 | |
| AKGKKAAKVVPVKAK | 216 | P19338 | |
| KKSPGKVKEVNLQKK | 131 | Q9UMY1 | |
| KKVSFTIKPKEKIGI | 1211 | O15440 | |
| ISKKGFKKAVVKTQK | 11 | Q96A08 | |
| KVKTPIKKQEAKKKA | 306 | Q8TAL5 | |
| KEKKVVKPVRKVQKV | 391 | Q5VT06 | |
| VSKIFQVVPKKKERK | 316 | Q5TF58 | |
| KLKAKVVVKKADGFP | 1531 | O15021 | |
| LEIKGKKQKRIKPKE | 461 | Q17RS7 | |
| VTVVKFNPKIFKKKQ | 271 | P54198 | |
| VAKSAKKVKTPQPKK | 171 | P16402 | |
| SNALVLPGKKKKKTK | 46 | Q8IY37 | |
| EVVNPKKKGKKKKYT | 266 | Q86YQ8 | |
| KKIKTQEKAPVKKIN | 91 | P41218 | |
| GPVKTLTRKKNKKKK | 21 | Q9GZR2 | |
| PLVKPKIVKKRTKKF | 6 | P62910 | |
| VVKKKNKAGVSVKPF | 361 | Q02880 | |
| IKGKVGKPKVKKLQL | 1216 | Q02880 | |
| LNQEKPKVKKRKGKF | 486 | Q5TCX8 | |
| VKKLPGVMLFKKKKT | 326 | Q86YW0 | |
| APFQKIAKKKLRKKD | 151 | Q9H1J1 | |
| KTYIPPKGETKKKFK | 76 | B2RPK0 | |
| ITLGAKKKEKVKPRK | 831 | Q9P2F8 | |
| FVTAFKKGKLKPVIK | 501 | P13667 | |
| KKQKKKKKPEVFNFS | 271 | Q9NVU7 | |
| KSNLKLPKGILKKKV | 401 | Q9H093 | |
| GKLFAVKCIPKKALK | 46 | Q8IU85 | |
| KVKVEVKKFVKIGRP | 101 | Q15428 | |
| KSQKGPAKTKKLKIE | 46 | Q14690 | |
| QKKLGIVPKQKYKIS | 106 | Q8IXW5 | |
| KKSKPKKCVKKFVEY | 381 | Q9H3U7 | |
| MAPVKKLVVKGGKKK | 1 | P35268 | |
| KLVVKGGKKKKQVLK | 6 | P35268 | |
| FQKVKLKVGKKKPKL | 11 | Q9NXF1 | |
| VFKSKNKIVIPKKKG | 251 | Q68CL5 | |
| KQTTLAFKPIKKGKK | 1276 | P11388 | |
| GVISKKAKVKVPQKT | 96 | Q96N20 | |
| VLVFIKKVAKKPTNK | 211 | P25942 | |
| VFSPKKGQKKKSIEK | 991 | Q5T200 |